PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-May-2019 PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery Polypid Ltd.
21-May-2019 PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery Polypid Ltd.
21-May-2019 STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer STADA Arzneimittel AG
21-May-2019 IME Medical Electrospinning Launches MediSpin XL™, a Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices B3C newswire
21-May-2019 Oncopeptides AB: INTERIM REPORT Q1 2019 Oncopeptides AB
21-May-2019 Dermapharm Holding SE: First quarter of 2019 characterized by profitable growth Dermapharm Holding SE
20-May-2019 EVOTEC JUMP-STARTS BIOLOGICS WITH ACQUISITION OF JUST BIOTHERAPEUTICS Evotec SE
20-May-2019 Evotec SE to acquire Just Biotherapeutics, Inc. Evotec SE
20-May-2019 Insmed Announces Proposed Public Offering of Common Stock Insmed Incorporated
20-May-2019 Biom'up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City Biom'up
20-May-2019 Catalent Completes Acquisition Of Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion Catalent
20-May-2019 HAEMATO AG: HAEMATO AG published the Annual Report 2018 on 6 May 2019. In the first quarter of 2019, HAEMATO AG's sales amounted to EUR 48.4 million. HAEMATO AG
20-May-2019 Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss Rinri Therapeutics
20-May-2019 Promedior Announces Positive Long-term Safety and Efficacy Data from Open Label Extension Study of PRM-151 in Idiopathic Pulmonary Fibrosis Promedior
20-May-2019 emotive launches dedicated Advanced Therapies Business Unit emotive
20-May-2019 Registration is now open for the inaugural Wearable Injectors and Connected Devices Conference 2019 SMi Group
20-May-2019 New Post-hoc Analysis Shows Adding UPTRAVI® (selexipag) Versus Placebo Improved Long-Term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early Actelion Pharmaceuticals Ltd
20-May-2019 QPS Announces 170 Percent Revenue Growth For In Vitro Studies Across Europe QPS
20-May-2019 First Major Professional Sporting Team To Be Sponsored By CBD Hemp Company At Indy 500 Craft 1861
20-May-2019 Three DB102 (Enzastaurin) Presentations at ASCO and the 15th International Conference on Malignant Lymphoma (ICML) Denovo Biopharma